Tissue plasminogen activator: why the backlash?
Topol
E J
EJ
Department of Medicine, University of Michigan Medical Center, Ann Arbor 48109-0022.
Califf
R M
RM
D002986:Clinical Trials as Topic; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy*; D010919:Placebos; D011897:Random Allocation; D011994:Recombinant Proteins / Q000627:therapeutic use; D013300:Streptokinase / Q000627:therapeutic use; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use*
D010919:Placebos; D011994:Recombinant Proteins; D013300:Streptokinase; D010959:Tissue Plasminogen Activator